PERMANENT LIFE SUPPORT SET
Report
- Report Number
- 8010762-2015-00233
- Event Type
- Death
- Date Received
- March 18, 2015
- Date of Event
- February 18, 2015
- Manufacturer
- MAQUET CARDIOPULMONARY AG
- Product Code
- KFM
- PMA / PMN Number
- K101153
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
MAQUET CARDIOPULMONARY IS AWARE OF SIMILAR COMPLAINTS FROM THIS PRODUCT. SIMILAR PRODUCTS, SHOWING A SIMILAR MALFUNCTION, HAVE BEEN TESTED AND UNDER OPTICAL MICROSCOPE DELAMINATION OF SOME GAS FIBERS WERE OBSERVED. HENCE, THE PRIMING SOLUTION OR BLOOD WAS ABLE TO FLOW INSIDE THE GAP BETWEEN THE GAS FIBERS AND POLYURETHANE AND THE GRAVITY GUIDED IT TO THE GAS EXITING PATH ALONG THE HOUSING. THE MANUFACTURER INITIATED A CUSTOMER NOTIFICATION CONCERNING THE PROBLEM, THE POTENTIAL RISK AND THE RECOMMENDED HANDLING IN THE EVENT THIS FAILURE OCCURS (FSCA# (B)(4)). THE INVESTIGATION UNDER CAPA PROCESS (CAPA (B)(4)) HAS IDENTIFIED THAT THE ROOT CAUSE IS DUE TO THE MANUFACTURING PROCESS OF THE RAW MATERIAL FIBERS USED IN THE OXYGENATOR. IF, DURING THE SURFACE PRE-TREATMENT, A SYSTEM MALFUNCTION RESULTS IN A SYSTEM STOP, THE ENTIRE LENGTH OF THE FIBER IS NOT PROPERLY TREATED TO MODIFY THE SURFACE TENSION. IF THESE UNTREATED FIBERS ARE PRESENT IN THE EPOXY AREA OF THE OXYGENATOR, IT IS NOT PROPERLY FIXED IN THE EPOXY. WHEN THIS OCCURS, THE FIBERS ARE ABLE TO "SHRINK OUT" OF THE EPOXY AND RESULT IN THE REPORTED LEAKAGE. THE RAW MATERIAL MANUFACTURER HAS INITIATED STEPS TO REPEAT THE SURFACE PRE-TREATMENT TO ENSURE THAT THE PROPER SURFACE TENSION IS PRESENT ON THE ENTIRE LENGTH OF THE FIBERS. ADDITIONAL INFORMATION: THE PRODUCT MENTIONED UNDER SECTION D IS NOT DISTRIBUTED TO THE US, BUT THE PRODUCT WITH CONTRIBUTING DESIGN FUNCTION TO THE AFFECTED COMPONENT (QUADROX-ID) IS REGISTERED UNDER 510(K): K101153.
DESCRIPTION FROM THE CUSTOMER REPORT: A BLOOD LEAKAGE WAS NOTICED AT THE GAS OUTLET OF THE OXYGENATOR 2 HOURS AFTER PUTTING IN PLACE THE SET. ACTIONS TAKEN: MONITORING AND REPLACEMENT OF THE SET WILL BE DONE WHEN THE PATIENT IS STABLE. ADDITIONAL INFO RECEIVED ON 02/23/2015: NO CLINICAL CONSEQUENCE DUE TO THE EVENT WAS REPORTED. THE PATIENT DIED BUT THE CUSTOMER STATED THAT THERE WAS NO LINK BETWEEN THE DEATH OF THE PATIENT AND THE (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 185486 | PERMANENT LIFE SUPPORT SET | BE-PLS 2050#PERMANENT LIFE SUPPORT SET | KFM | MAQUET CARDIOPULMONARY AG | BE-PLS 2050 | 70100002 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Death |